Bristol-Myers Squibb ditches PwC

Pharmaceutical giant Bristol-Myers Squibb has dismissed
PricewaterhouseCoopers as its auditor and replaced it with Deloitte.

In a filing with the Securities & Exchange Commission, the New York-based
company, said it had no accounting disagreements with PwC and gave no reason for
switching auditors.

In its filing, the company also disclosed that it had approved a $2.22m
(£1.26m) 2005 bonus for chief executive Peter Dolan.

Related reading